Investor Relations

Stock Price:   NYSE: BIO  
Scientist using Bio-Rad gel

Helping to Provide a Greater Understanding of Biological Systems and Diseases

Investing in the future of better healthcare for all

A global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare.

Q3 2021 Financial Results

Press Releases

Bio-Rad to Participate in Fireside Chat During the 40th Annual J.P. Morgan Healthcare Conference on January 11

Bio-Rad Appoints Simon May Executive Vice President and Life Science Group President

Bio-Rad Reports Third-Quarter 2021 Financial Results

View All Press Releases »

Investor Kit

Bio-Rad Dec. 2020 Investor Update Presentation Investor Presentation
Form 10-K 2020 Form 10-K
Proxy Statement 2021 Proxy Statement
Latest Form 10-Q 10-Q

Transfer Agent:
c/o Shareholder Services
462 South 4th Street, Suite 1600
Louisville, KY 40202
800-962-4284 (within the U.S.)
781-575-3120 (outside the U.S.)

Contact Information

  • Investor Relations

    Edward Chung, Vice President, Investor Relations